Nothing succeeds like success. Genentech CEO Arthur Levinson took in a handy $3 million in salary and bonuses for last year, but pocketed more than $66 million from the sale of his stock options. Genentech has been racking up big gains over the last three years with a string of impressive clinical trial results. That data has helped quadruple the company's stock price, which has in turn earned impressive rewards for the CEO.
- read The Wall Street Journal report (sub. req.)